PrefixTitleTypeCategory
B7No difference in urine tenofovir levels in patients living with HIV on unboosted vs dose-adjusted boosted tenofovir alafenamideE-posterART adherence measurement
B7Effect of digital adherence tools on adherence to antiretroviral treatment among adults living with HIV in Kilimanjaro, Tanzania: a randomised controlled trialE-posterART adherence measurement
B8HIV-1 drug resistance mutations in proviruses of early treated infants in BotswanaE-posterDrug resistance testing
B8Integrase genotyping is highly effective on diverse HIV-1 non-B clades circulating in Cameroon: toward a successful transition to dolutegravir-based regimens in AfricaE-posterDrug resistance testing
B9Combination of Xpert® MTB/RIF and DetermineTM TB LAM assay improves the diagnosis of extrapulmonary tuberculosis at Jimma University Medical Center, Southwest EthiopiaE-posterDiagnosis of co-infections and co-morbidities
B9Serum CA-125 in the diagnosis and therapeutic monitoring of tuberculosis in HIV infected patientsE-posterDiagnosis of co-infections and co-morbidities
B9Values & preferences on hepatitis C self-testing among populations at increased risk of HCV, healthcare workers, and the general population: a multi-country rapid qualitative assessmentE-posterDiagnosis of co-infections and co-morbidities
B11Gender differences among patients with drug resistant tuberculosis and HIV co-infection in Uganda: a countrywide retrospective cohort studyE-posterTuberculosis and other mycobacteria
B11Investigating isoniazid prevention therapy completion rate among adult HIV patients on antiretroviral therapy and its effectiveness in preventing tuberculosis at Katutura Hospital, Namibia, 2014-2018E-posterTuberculosis and other mycobacteria
B12Epidemiological trends of hepatitis B morbidity and mortality in Greece, Italy, Portugal and Spain, 2000-2019: a systematic analysis from the Global Burden of Disease Study 2019E-posterViral hepatitis A, B, D and E
231 - 240 of 870 items